Dr Jurgen Beckmann, Germany

The parties involved in information exchange of adverse drug reactions are the general public, patients, journalists, lawyers, politicians, healthcare professionals, product licence holders, academia, WHO, and drug regulatory authorities.

The information provided by and for the various parties can be primary information such as adverse drug reaction single case reports, results from studies, or assessed information, such as drug-ADR associations, signals, alerts, assessments reports, and actions.

Several ways of transmitting this information are available - hard copy, electronic format, or through personal contact.